Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations

PLoS Genetics

Volumn 14, Issue 12, 2018, Pages

  Rajabli, Farid ^a   Feliciano, Briseida E ^b   Celis, Katrina ^a   Hamilton Nelson, Kara L ^a   Whitehead, Patrice L ^a   Adams, Larry D ^a   Bussies, Parker L ^a   Manrique, Clara P ^a   Rodriguez, Alejandra ^b   Rodriguez, Vanessa ^a   Starks, Takiyah ^c   Byfield, Grace E ^c   Sierra Lopez, Carolina B ^b   McCauley, Jacob L ^a   Acosta, Heriberto ^d   Chinea, Angel ^b   Kunkle, Brian W ^a   Reitz, Christiane ^e   Farrer, Lindsay A ^f   Schellenberg, Gerard D ^g   Vardarajan, Badri N ^e   Vance, Jeffery M ^a   Cuccaro, Michael L ^a   Martin, Eden R ^a   Haines, Jonathan L ^h   Byrd, Goldie S ^c   Beecham, Gary W ^a   Pericak Vance, Margaret A ^a   more..

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD CENTRAL DEL CARIBE   (United States)

^c NORTH CAROLINA A AND T STATE UNIVERSITY   (United States)

^d Clinica de la Memoria   (United States)

^e Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ALZHEIMER DISEASE; ANCESTRY GROUP; APOE GENE; ARTICLE; CONTROLLED STUDY; EUROPEAN; FEMALE; GENE; GENETIC RISK; GENOME ANALYSIS; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PUERTO RICAN; RISK ASSESSMENT; VERY ELDERLY; CASE CONTROL STUDY; ETHNOLOGY; GENE FREQUENCY; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HISPANIC; POPULATION GENETICS; PUERTO RICO; RISK FACTOR;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC VARIATION; GENETICS, POPULATION; GENOME-WIDE ASSOCIATION STUDY; HISPANIC AMERICANS; HUMANS; MALE; PUERTO RICO; RISK FACTORS;

EID: 85058899273     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1007791     Document Type: Article

References (39)

1. Hebert LE, Weuve J, Scherr PA, Evans DA, Alzheimer disease in the United States (2010–2050) estimated using the 2010 Census. Neurology. 2013;80:1778–83. doi: 10.1212/WNL.0b013e31828726f5 pmid: 23390181
2. Borenstein AR, Mortimer JA, Alzheimer Disease Life Course Perspectives on Risk Reduction. San Diego, CA: Elseiver; 2016
3. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–923. pmid: 8346443
4. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Jret al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994;7(2):180–4. doi: 10.1038/ng0694-180 pmid: 7920638
5. Conejero-Goldberg C, Gomar JJ, Bobes-Bascaran T, Hyde TM, Kleinman JE, Herman MM, et al. APOE2 enhances neuroprotection against Alzheimer’s disease through multiple molecular mechanisms. Mol Psychiatry. 2014;19:1243–1250. doi: 10.1038/mp.2013.194 pmid: 24492349
6. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA. 1997;278(16):1349–1356. pmid: 9343467
7. Liu M, Bian C, Zhang J, Wen F, Apolipoprotein E gene polymorphism and Alzheimer’s disease in Chinese population: a meta-analysis. Sci Rep. 2014;4:4383. doi: 10.1038/srep04383 pmid: 24632849
8. Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA. 1998;279:751–755. pmid: 9508150
9. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology. 2001;56(1) 49–56. pmid: 11148235
10. Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, et al. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet. 1996;58(3): 574–584. pmid: 8644717
11. Sahota A, Yang M, Gao S, Hui SL, Baiyewu O, Gureje O, et al. Apolipoprotein E-associated risk for Alzheimer’s disease in the African-American population is genotype dependent. Ann Neurol. 1997;42:659–661. doi: 10.1002/ana.410420418 pmid: 9382479
12. Hendrie HC, Murrell J, Baiyewu O, Lane KA, Purnell C, Ogunniyi A, et al. APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba. Int Psychogeriatr. 2014;26(9)977–985
13. Graff-Radford NR, Green RC, Go RC, Hutton ML, Edeki T, Bachman D, et al. Association Between Apolipoprotein E Genotype and Alzheimer Disease in African American Subjects. Arch Neurol. 2002; 59(4):594–600. pmid: 11939894
14. Farrer LA, Friedland RP, Bowirrat A, Waraska K, Korczyn A, Baldwin CT, Genetic and environmental epidemiology of Alzheimer’s disease in arabs residing in Israel. J Mol Neurosci. 2003;20(3):207–12. doi: 10.1385/JMN:20:3:207 pmid: 14500999
15. Henderson JN, Crook R, Crook J, Hardy J, Onstead L, Carson-Henderson L, et al. Apolipoprotein E4 and tau allele frequencies among Choctaw Indians. Neurosci Lett. 2002;324(1):77–9. pmid: 11983299
16. Bowirrat A, Friedland RP, Chapman J, Korczyn AD, The very high prevalence of AD in an Arab population is not explained by APOE epsilon4 allele frequency. Neurology. 2000;55(5):731
17. Mersha TB, Abebe T, Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities. Hum Genomics. 2015;7:9:1
18. Gravlee CC, Non AL, Mulligan CJ, Genetic ancestry, social classification, and racial inequalities in blood pressure in Southeastern Puerto Rico. PLoS One. 2009;4(9):e6821. doi: 10.1371/journal.pone.0006821 pmid: 19742303
19. Aldrich MC, Selvin S, Wrensch MR, Sison JD, Hansen HM, Quesenberry CP, Jret al. Socioeconomic status and lung cancer: unraveling the contribution of genetic admixture. Am J Public Health. 2013;103(10):e73–80. doi: 10.2105/AJPH.2013.301370 pmid: 23948011
20. Fenesi B, Fang H, Kovacevic A, Oremus M, Raina P, Heisz JJ, Physical Exercise Moderates the Relationship of Apolipoprotein E (APOE) Genotype and Dementia Risk: A Population-Based Study. J Alzheimers Dis. 2017;56(1):297–303. doi: 10.3233/JAD-160424 pmid: 27911292
21. Martin ER, Tunc I, Liu Z, Slifer SH, Beecham A, Beecham G, Properties of global- and local-ancestry adjustments in genetic association tests in admixed populations. Genet Epidemiol. 2018;42(2):214–229. doi: 10.1002/gepi.22103 pmid: 29288582
22. Zhu X, Wang H, The Analysis of Ethnic Mixtures. Methods Mol Biol. 2017;1666:505–525. doi: 10.1007/978-1-4939-7274-6_25 pmid: 28980262
23. Reitz C, Jun G, Naj A, Vardarajan BN, Wang LS, Valladares O, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4, and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013;309:1483–1492. doi: 10.1001/jama.2013.2973 pmid: 23571587
24. Cukier HN, Kunkle BW, Vardarajan BN, Rolati S, Hamilton-Nelson KL, Kohli MA, et al. ABCA7 frameshift deletion with Alzheimer disease in African Americans. Neurol Genet.2016;2(3):e79. doi: 10.1212/NXG.0000000000000079 pmid: 27231719
25. McKhann G, Drachman D, Folstein M, Katzman R, Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology.1984;34(7): 939–44. pmid: 6610841
26. Albert MS, Dekosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement.2011;7:270–9. doi: 10.1016/j.jalz.2011.03.008 pmid: 21514249
27. Wijsman EM, Pankratz ND, Choi Y, Rothstein JH, Faber KM, Cheng R, et al. Genome-wide association of familial late-onset Alzheimer’s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet. 2011;7:e1001308doi: 10.1371/journal.pgen.1001308 pmid: 21379329
28. Folstein MF, Folstein SE, McHugh PR, "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res.1975;12(3):189–98. pmid: 1202204
29. Teng EL, Chui HC, The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry.1987;48(8):314–8. pmid: 3611032
30. Saunders AM, Hulette C, Welsh-Bohmer KA, Schmechel DE, Crain B, Burke JR, et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer’s disease. Lancet.1996;348(9020):90–93. pmid: 8676723
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet.2007; 81(3):559–75doi: 10.1086/519795 pmid: 17701901
32. Anderson AC, Petterson FH, Clarke GM, Cardon LR, Morris AP, Zondervan KT, Data quality control in genetic case-control association studies. Nat Protoc. 2010;5(9): 1564–1573. doi: 10.1038/nprot.2010.116 pmid: 21085122
33. Delaneau O, Marchini J, The 1000 Genomes Project ConsortiumIntegrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel. Nature Communications.2014;5:3934. doi: 10.1038/ncomms4934 pmid: 25653097
34. The 1000 Genomes Project ConsortiumA global reference for human genetic variation. Nature.2015;526: 68–74doi: 10.1038/nature15393 pmid: 26432245
35. Maples BK, Gravel S, Kenny EE, Bustamante CD, RFMix: a discriminative modeling approach for rapid and robust local-ancestry inference. Am. J. Hum. Genet.2013;93:278–288doi: 10.1016/j.ajhg.2013.06.020 pmid: 23910464
36. Price AL, Patterson N, Plenge RM, Weinblatt ME, Shadick NA, Reich D, Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet.2006;904–909. doi: 10.1038/ng1847 pmid: 16862161
37. Marschner I. glm2: Fitting Generalized Linear Models. R package version 1.1.2.2014;https://CRAN.R-project.org/package=glm2
38. Vincent JC. gee:Generalized Estimation Equation Solver. R package version 4.13–19.2015;https://CRAN.R-project.org/package=gee
39. Dunn OJ, Multiple Comparisons Among Means. Journal of the American Statistical Association.1961;56 (293): 52–64